LL-37 is the only human cathelicidin-derived antimicrobial peptide, a 37-residue amphipathic helix released from the hCAP18 precursor. It sits at the intersection of innate immunity and tissue repair research.
Product Specifications:
- Purity: ≥99% (HPLC Verified)
- Form: Lyophilized Powder
- Unit Size: 5mg per vial
- Storage: Store at -20°C or lower
- Usage: Laboratory research use only
Research Applications:
LL-37 is widely used in work on:
- Bacterial membrane disruption assays
- Innate immune response modelling
- Biofilm formation and inhibition
- Wound healing and keratinocyte migration
Note: Supplied for in vitro research. Not intended for administration to humans or animals.
Questions about specifications or certificates of analysis? Send them through our contact form.
Purity: ≥99% (HPLC verified)
Form: Lyophilised powder
Storage: Store at −20°C or lower
Reconstitution: Bacteriostatic water (sold separately)
Usage: Laboratory research use only